Clin Mol Hepatol.
2024 Oct;30(4):989-991. 10.3350/cmh.2024.0705.
Correspondence to editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
- Affiliations
-
- 1College of Pharmacy, Korea University, Sejong, Korea
- 2Division of Endocrinology & Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
- 3College of Pharmacy, Ewha Womans University, Seoul, Korea
- 4Institute of Pharmaceutical Science, Korea University, Sejong, Korea
- KMID: 2560104
- DOI: http://doi.org/10.3350/cmh.2024.0705
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
- Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle: Editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis”
- Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
- The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
- Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Antidiabetic Agents
